Quest Diagnostics 

$185
228
-$2.03-1.09% Monday 21:00

Statistics

Day High
186.93
Day Low
182.36
52W High
197.55
52W Low
157.2
Volume
743,895
Avg. Volume
1,025,572
Mkt Cap
20.58B
P/E Ratio
20.65
Dividend Yield
1.73%
Dividend
3.2

Upcoming

Dividends

1.73%Dividend Yield
Jan 26
$0.8
Oct 25
$0.8
Jul 25
$0.8
Apr 25
$0.8
Jan 25
$0.75
10Y Growth
7.31%
5Y Growth
5.75%
3Y Growth
4.68%
1Y Growth
1.59%

Earnings

10FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
2.15
2.31
2.46
2.62
Expected EPS
2.362723
Actual EPS
N/A

Financials

8.82%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
19.74BRevenue
1.74BNet Income

Analyst Ratings

$202.38Average Price Target
The highest estimate is 215.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
38%
Hold
63%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DGX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap21.08B
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences Corporation is known for its non-invasive screening test for colorectal cancer, competing in the diagnostics market.
Neogenomics
NEO
Mkt Cap1.26B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap748.08M
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

About

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Show more...
CEO
Mr. James E. Davis
Employees
55000
Country
US
ISIN
US74834L1008

Listings

0 Comments

Share your thoughts

FAQ

What is Quest Diagnostics stock price today?
The current price of DGX is $185 USD — it has decreased by -1.09% in the past 24 hours. Watch Quest Diagnostics stock price performance more closely on the chart.
What is Quest Diagnostics stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quest Diagnostics stocks are traded under the ticker DGX.
Is Quest Diagnostics stock price growing?
DGX stock has risen by +0.41% compared to the previous week, the month change is a +6.45% rise, over the last year Quest Diagnostics has showed a +13.87% increase.
What is Quest Diagnostics market cap?
Today Quest Diagnostics has the market capitalization of 20.58B
When is the next Quest Diagnostics earnings date?
Quest Diagnostics is going to release the next earnings report on February 10, 2026.
What were Quest Diagnostics earnings last quarter?
DGX earnings for the last quarter are 2.6 USD per share, whereas the estimation was 2.5 USD resulting in a +3.87% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quest Diagnostics revenue for the last year?
Quest Diagnostics revenue for the last year amounts to 19.74B USD.
What is Quest Diagnostics net income for the last year?
DGX net income for the last year is 1.74B USD.
Does Quest Diagnostics pay dividends?
Yes, DGX dividends are paid quarterly. The last dividend per share was 0.8 USD. As of today, Dividend Yield (FWD)% is 1.73%.
How many employees does Quest Diagnostics have?
As of February 03, 2026, the company has 55,000 employees.
In which sector is Quest Diagnostics located?
Quest Diagnostics operates in the Health Care sector.
When did Quest Diagnostics complete a stock split?
The last stock split for Quest Diagnostics was on June 21, 2005 with a ratio of 2:1.
Where is Quest Diagnostics headquartered?
Quest Diagnostics is headquartered in Secaucus, US.